Matches in Wikidata for { <http://www.wikidata.org/entity/Q37304652> ?p ?o ?g. }
- Q37304652 description "article científic" @default.
- Q37304652 description "article scientifique" @default.
- Q37304652 description "articolo scientifico" @default.
- Q37304652 description "artigo científico" @default.
- Q37304652 description "artículu científicu espublizáu en 2016" @default.
- Q37304652 description "bilimsel makale" @default.
- Q37304652 description "scientific article published on 28 May 2016" @default.
- Q37304652 description "vedecký článok" @default.
- Q37304652 description "vetenskaplig artikel" @default.
- Q37304652 description "videnskabelig artikel" @default.
- Q37304652 description "vědecký článek" @default.
- Q37304652 description "wetenschappelijk artikel" @default.
- Q37304652 description "wissenschaftlicher Artikel" @default.
- Q37304652 description "наукова стаття, опублікована в травні 2016" @default.
- Q37304652 description "научни чланак" @default.
- Q37304652 description "գիտական հոդված հրատարակված 2016 թվականի մայիսի 28-ին" @default.
- Q37304652 description "مقالة علمية نشرت في 28 مايو 2016" @default.
- Q37304652 name "Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma" @default.
- Q37304652 name "Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma" @default.
- Q37304652 name "Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma" @default.
- Q37304652 type Item @default.
- Q37304652 label "Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma" @default.
- Q37304652 label "Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma" @default.
- Q37304652 label "Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma" @default.
- Q37304652 prefLabel "Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma" @default.
- Q37304652 prefLabel "Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma" @default.
- Q37304652 prefLabel "Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma" @default.
- Q37304652 P1433 Q37304652-DE6E3DD4-0E9B-43B3-A7D0-DFC4D25F7CBE @default.
- Q37304652 P1476 Q37304652-ADB51E6B-9DA2-48DA-BBCC-C5D031424C67 @default.
- Q37304652 P2093 Q37304652-0C200A1F-9DD7-4550-B634-D60563AABE21 @default.
- Q37304652 P2093 Q37304652-19D5E599-BCDB-4E11-9225-B16DB3AC2481 @default.
- Q37304652 P2093 Q37304652-1F153DBC-BE47-4BE8-BD03-0033326C7519 @default.
- Q37304652 P2093 Q37304652-75434DE8-6C72-4767-BF76-9C285002E003 @default.
- Q37304652 P2093 Q37304652-89BEE52B-0410-4D69-A4BD-7ABA7B8838D0 @default.
- Q37304652 P2093 Q37304652-A673BE17-D2EF-422C-8AF3-65BBBB3499BE @default.
- Q37304652 P2093 Q37304652-DFB54276-62EF-46BA-B3A3-C6A9B0B0C9FC @default.
- Q37304652 P2093 Q37304652-ECB8561D-9083-4D65-9C4F-E6CBF5E49CFF @default.
- Q37304652 P2860 Q37304652-0A5A88BF-84AD-4469-AA81-A8A1376B88B6 @default.
- Q37304652 P2860 Q37304652-0A8A6693-92C2-46A8-8097-CDE487EDC90A @default.
- Q37304652 P2860 Q37304652-0F5D24CB-D167-4711-8457-70C528FA5998 @default.
- Q37304652 P2860 Q37304652-15D40130-B4E2-4CAF-9402-96C95D91DD1C @default.
- Q37304652 P2860 Q37304652-2424B6CB-24BA-41AA-B009-2333767A8BEA @default.
- Q37304652 P2860 Q37304652-29AB4DE9-64CB-4E57-986B-08C6B176E810 @default.
- Q37304652 P2860 Q37304652-2A1AAB10-EE2D-4FE2-BC18-17919F5CAD48 @default.
- Q37304652 P2860 Q37304652-3B59E3F0-1083-45A5-98E5-F24AF3C7A081 @default.
- Q37304652 P2860 Q37304652-45DA20E6-BB04-4A8A-92E5-3958D5CD7AAB @default.
- Q37304652 P2860 Q37304652-462F13AD-ACB1-4BA7-BFFC-8242D8B94F01 @default.
- Q37304652 P2860 Q37304652-469334B6-75BF-4AE4-9C42-7DA543C84AE1 @default.
- Q37304652 P2860 Q37304652-4F1616C6-7330-4C26-8A3F-3E7BE6C0D900 @default.
- Q37304652 P2860 Q37304652-52E4D37B-9D85-4B88-9061-ADE2F124DA30 @default.
- Q37304652 P2860 Q37304652-61B6EB19-091D-4F65-B1B9-A975D7CE449E @default.
- Q37304652 P2860 Q37304652-62AFC12F-F0C1-4F6B-88A8-2CFD9BE48186 @default.
- Q37304652 P2860 Q37304652-656F217E-63B4-44CE-A20D-693582007E4B @default.
- Q37304652 P2860 Q37304652-70C227D7-E384-40BF-B83A-87581DAE6E2B @default.
- Q37304652 P2860 Q37304652-8085F70A-D955-495B-9815-0722E98734B2 @default.
- Q37304652 P2860 Q37304652-85108B1A-33EF-4AAF-B131-C95E0F06D915 @default.
- Q37304652 P2860 Q37304652-85B0B561-805E-4053-B036-3DC9863A5636 @default.
- Q37304652 P2860 Q37304652-8F05B3C8-08F7-4787-9E8F-4FBAF67951B1 @default.
- Q37304652 P2860 Q37304652-9B6DBFB0-9AEB-4194-B22C-47197A420D4A @default.
- Q37304652 P2860 Q37304652-A02396BB-9385-4868-9BB2-B04E53655738 @default.
- Q37304652 P2860 Q37304652-A239B529-A7C8-4992-93F9-1AC3D455BB03 @default.
- Q37304652 P2860 Q37304652-AF3D558E-8549-402B-BC06-171EFEC02D7C @default.
- Q37304652 P2860 Q37304652-B54F8DD1-CF3C-43F2-A93D-F6AE13240F6A @default.
- Q37304652 P2860 Q37304652-D02002EE-13B6-489B-86FC-E39476AEEA0F @default.
- Q37304652 P2860 Q37304652-D043D8AD-8C6F-4B5E-96E3-FF7E193A2C33 @default.
- Q37304652 P2860 Q37304652-D8CD273C-62C7-49E1-9355-0B842FC72465 @default.
- Q37304652 P2860 Q37304652-DAC5C6A5-4060-41E7-B999-1A339250F150 @default.
- Q37304652 P2860 Q37304652-E1A86E05-D950-480B-9172-2289EFE30974 @default.
- Q37304652 P2860 Q37304652-EBEB8159-CDC3-4073-B4F6-23A572E7CDD3 @default.
- Q37304652 P2860 Q37304652-F504BC93-5389-4895-8A22-DD0D9BEAE0CE @default.
- Q37304652 P304 Q37304652-11E8B918-17E4-4EF0-B459-A0F0B70F010B @default.
- Q37304652 P31 Q37304652-86790F7B-3947-4B02-B1B3-CEE205084A29 @default.
- Q37304652 P356 Q37304652-83EDAE67-2FD0-49EA-9D61-F91102B26BAF @default.
- Q37304652 P407 Q37304652-ACB5806A-6A18-465F-928C-66E14908AE81 @default.
- Q37304652 P478 Q37304652-26D08595-F832-47A9-8BB2-1E10D0FC8504 @default.
- Q37304652 P50 Q37304652-3CA77FCE-D21F-4062-92B7-EE1902DB17EF @default.
- Q37304652 P50 Q37304652-6B10A8B8-AA7B-4495-9155-55AEE0AAAAB0 @default.
- Q37304652 P577 Q37304652-B787CEAB-FA0F-49FA-B99B-1195064905F8 @default.
- Q37304652 P698 Q37304652-0DA14F10-A2CA-49BA-8D75-90EB99ABA65D @default.
- Q37304652 P921 Q37304652-17EEB108-8AE3-469F-990B-91EBB2B3F590 @default.
- Q37304652 P921 Q37304652-5AB50623-B2CD-43A7-82A1-950BDF41EA66 @default.
- Q37304652 P921 Q37304652-6831CC4F-D09A-4C23-BC85-062E696503AA @default.
- Q37304652 P932 Q37304652-85DA42E0-585B-4068-BD6F-CF9FD56B25BA @default.
- Q37304652 P356 J.ORALONCOLOGY.2016.05.011 @default.
- Q37304652 P698 27311401 @default.
- Q37304652 P1433 Q7099367 @default.
- Q37304652 P1476 "Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma" @default.
- Q37304652 P2093 "András Schaffer" @default.
- Q37304652 P2093 "Anthony Robinson" @default.
- Q37304652 P2093 "Douglas Adkins" @default.
- Q37304652 P2093 "James Lewis" @default.
- Q37304652 P2093 "Jessica Ley" @default.
- Q37304652 P2093 "Loren Michel" @default.
- Q37304652 P2093 "Se-Eun Chun" @default.
- Q37304652 P2093 "Wooin Lee" @default.
- Q37304652 P2860 Q21195212 @default.
- Q37304652 P2860 Q27851567 @default.
- Q37304652 P2860 Q27851724 @default.
- Q37304652 P2860 Q27853110 @default.
- Q37304652 P2860 Q28256121 @default.